Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 3/20 | 0.43 |
| ▸ | MME | P08473 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.41 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 13/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 11/20 | 0.39 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.37 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL659350 | 0.82 | ACACB (0.50) | ACACBMMEROCK2ROCK1 | |
| SCHEMBL22618859 | 0.78 | ACACB (0.47) | ACACBMMEROCK2ROCK1 | |
| SCHEMBL28210633 | 0.78 | ACACB (0.45) | ACACBMMEROCK2ROCK1 | |
| SCHEMBL34468847 | 0.75 | ACACB (0.52) | ACACBMMEROCK2ROCK1 | |
| SCHEMBL30759740 | 0.74 | CA2 (0.50) | ACACBMMEROCK2ROCK1 | |
| SCHEMBL3633530 | 0.74 | — | — | |
| SCHEMBL872179 | 0.74 | — | — | |
| SCHEMBL4876707 | 0.74 | — | — | |
| SCHEMBL28350299 | 0.74 | — | — | |
| SCHEMBL1085922 | 0.73 | ALDH1A1 (0.41) | ACACBMMEALDH1A1HTTPIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129044-A1 | PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS | XENON PHARMACEUTICALS INC. (CA) | 2025-04-24 | — | — | US | disclosed |
| WO-2024140356-A1 | CATHEPSIN L INHIBITORS | BIOFRONT THERAPEUTICS (BEIJING) CO., LTD. (CN) | 2024-07-04 | — | — | WO | disclosed |
| US-20230150972-A1 | PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS | XENON PHARMACEUTICALS INC. (CA) | 2023-05-18 | — | — | US | disclosed |
| CN-110022875-A | Therapeutic inhibiting compound | 莱福斯希医药公司 | 2019-07-16 | — | — | CN | disclosed |
| EP-2925134-A1 | TERNARY FUNGICIDAL MIXTURES | Bayer CropScience AG (DE) | 2015-10-07 | — | — | EP | disclosed |
| WO-2014082950-A1 | TERNARY FUNGICIDAL MIXTURES | BAYER CROPSCIENCE AG (DE) | 2014-06-05 | — | — | WO | disclosed |
| US-20120035165-A1 | Use of fungicidal compound compositions for controlling certain rust fungi | BAYER CROPSCIENCE AG (DE) | 2012-02-09 | — | — | US | disclosed |
| US-20090239748-A1 | Fungicidal Mixtures Based on 2,5-Disubstituted N-Biphenylpyrazolcarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2009-09-24 | — | — | US | disclosed |
| US-20090233795-A1 | Fungicidal Mixtres Based On 3-Monosubstituted N-Bipenyl-Pyrazolecarboxamides | BASF AKITENGESELLSCHAFT (DE) | 2009-09-17 | — | — | US | disclosed |
| US-20090042724-A1 | Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | disclosed |
| US-20090042725-A1 | Fungicidal Mixtures Based on 3,5-Disubstituted N-Biphenyl-Pyrazolcarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042725-A1 | Fungicidal Mixtures Based on 3,5-Disubstituted N-Biphenyl-Pyrazolcarboxamides | CBR3, CBR1, STS | ACACB 1978/4885MME 1696/4885ALDH1A1 433/4885 |
| US-20250129044-A1 | PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS | SCN1B, SCN1A, SCN2B | ACACB 4474/4885MME 2850/4885ALDH1A1 1828/4885 |
| US-20090042724-A1 | Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides | CBR3, CBR1, SNU13 | ACACB 3079/4885MME 1183/4885ALDH1A1 1177/4885 |
| US-20090239748-A1 | Fungicidal Mixtures Based on 2,5-Disubstituted N-Biphenylpyrazolcarboxamides | CBR3, CBR1, SNU13 | ACACB 3161/4885MME 1383/4885ALDH1A1 1559/4885 |
| US-20090233795-A1 | Fungicidal Mixtres Based On 3-Monosubstituted N-Bipenyl-Pyrazolecarboxamides | CBR3, CBR1, CYCS | ACACB 3323/4885MME 2456/4885ALDH1A1 2391/4885 |
| US-20230150972-A1 | PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS | SCN1B, SCN1A, SCN2B | ACACB 4474/4885MME 2850/4885ALDH1A1 1828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.